Connecting the Human Microbiome and Pancreatic Cancer von Sexton, Rachel E., Uddin, Md Hafiz, Bannoura, Sahar, Khan, Husain Yar, Mzannar, Yousef, Li, Yiwei, Aboukameel, Amro, Al-Hallak, Mohammad Najeeb, Al-Share, Bayan, Mohamed, Amr, Nagasaka, Misako, El-Rayes, Bassel, Azmi, Asfar S.

Volltext

Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRAS G12C-Mutant Pancreatic and Lung Cancers von Khan, Husain Yar, Nagasaka, Misako, Aboukameel, Amro, Alkhalili, Osama, Uddin, Md. Hafiz, Bannoura, Sahar F., Mzannar, Yousef, Azar, Ibrahim, Beal, Eliza W., Tobon, Miguel E., Kim, Steve H., Beydoun, Rafic, Baloglu, Erkan, Senapedis, William, El-Rayes, Bassel F., Philip, Philip A., Mohammad, Ramzi M., Shields, Anthony F., Al Hallak, Mohammed Najeeb, Azmi, Asfar S.

Volltext

Correction to: Connecting the human microbiome and pancreatic cancer von Sexton, Rachel E., Uddin, Md Hafz, Bannoura, Sahar, Khan, Husain Yar, Mzannar, Yousef, Li, Yiwei, Aboukameel, Amro, Al-Hallak, Mohammad Najeeb, Al-Share, Bayan, Mohamed, Amr, Nagasaka, Misako, El-Rayes, Bassel, Azmi, Asfar S.

Volltext

Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung Cancers von Khan, Husain Yar, Nagasaka, Misako, Aboukameel, Amro, Alkhalili, Osama, Uddin, Md Hafiz, Bannoura, Sahar F, Mzannar, Yousef, Azar, Ibrahim, Beal, Eliza W, Tobon, Miguel E, Kim, Steve H, Beydoun, Rafic, Baloglu, Erkan, Senapedis, William, El-Rayes, Bassel F, Philip, Philip A, Mohammad, Ramzi M, Shields, Anthony F, Al Hallak, Mohammed Najeeb, Azmi, Asfar S

Volltext

Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C-Mutant Cancers von Khan, Husain Yar, Nagasaka, Misako, Li, Yiwei, Aboukameel, Amro, Uddin, Md Hafiz, Sexton, Rachel, Bannoura, Sahar, Mzannar, Yousef, Al-Hallak, Mohammed Najeeb, Kim, Steve, Beydoun, Rafic, Landesman, Yosef, Mamdani, Hirva, Uprety, Dipesh, Philip, Philip A, Mohammad, Ramzi M, Shields, Anthony F, Azmi, Asfar S

Volltext

Abstract 5315: Anti-tumor activity of KRASG12C inhibitors is enhanced when combined with Cdc42 effector p21-activated kinase 4 targeting agents von Khan, Husain Yar, Bannoura, Sahar, Mamdani, Hirva, Aboukameel, Amro, Mzannar, Yousef, Li, Yiwei, Al-Hallak, Mohammad Najeeb, Azar, Ibrahim, Kim, Steve, Beydoun, Rafic, Mohammad, Ramzi, Landesman, Yosef, Zhang, Yue, Baloglu, Erkan, Senapedis, William, Sukari, Ammar, Nagasaka, Misako, Shields, Anthony, Azmi, Asfar S.

Volltext